IL6 and COVID-19: Moreover, GAPDH normalization did not reveal any significant differences in the expression of IL-6 between asymptomatic and severely infected COVID-19 patients (Fig. 5) despite the fact that inflammation is minimal in asymptomatic patients and very high in patients having severe COVID-19 (39).